VP4.F
Healthcare Drug Manufacturers - Specialty & GenericVistin Pharma ASA
€1.67
+0.00 +0.00% today
Price History
Not enough data
Key Stats
Market Cap
74.28M
Avg Volume
0
P/E (TTM)
11.96
EPS
€0.14
52W High
€2.10
52W Low
€1.66
Div. Yield
89.6%
Valuation
P/B Ratio
2.51
P/S Ratio
0.17
EV/EBITDA
0.80
EV/Revenue
0.19
Margins
Gross Margin 67.6%
Operating Margin 16.0%
Net Margin 16.3%
EBITDA Margin 23.8%
Growth & Returns
Revenue Growth (YoY)
(14.8%)
Earnings Growth (YoY)
(23.5%)
Earnings Growth (QoQ)
(23.5%)
Return on Equity
22.9%
Return on Assets
11.6%
Liquidity & Leverage
Current Ratio
2.49
Quick Ratio
1.52
Debt / Equity
0.05
Total Cash
7.89M
Total Debt
16.32M
About
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; metformin direct compressible; and metformin premixed with lubricant magnesium stearate for use in plain metformin immediate release tablets. The company was founded in 1969 and is based in Oslo, Norway.
www.vistin.com